Robert T. Eagan
Mayo Clinic · 111 works · 3,536 citations · h-index 32
Top works
- Modern thirty-day operative mortality for surgical resections in lung cancer
- Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group
- VP-16, Cyclophosphamide, Adriamycin and Cis-platinum (V:CAP-I) in Patients with Metastatic Adenocarcinoma of the Lung
- Evaluation of response criteria in advanced lung cancer
- Small cell carcinoma of the lung: Staging, paraneoplastic syndromes, treatment, and survival
- Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.
- Combination chemotherapy and radiation therapy in small cell carcinoma of the lung
- Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer.
- Pilot study of induction therapy with cyclophosphamide, doxorubicin, and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non-small cell lung cancer.
- An analysis of a multiple‐drug program in the treatment of patients with advanced breast cancer utilizing 5‐fluorouracil, cyclophosphamide, and prednisone with or without vincristine
- Pleural lavage after pulmonary resection for bronchogenic carcinoma
- Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma
- Evaluation of alternating chemotherapy and sites and extent of disease in extensive small cell lung cancer
- cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
- Carcinosarcoma of the Lung: Mayo Clinic Experience and Response to Chemotherapy
- Evaluation of prognostic factors in chemotherapy of recurrent brain tumors.
- Meningeal Carcinomatosis in Patients With Primary Breast or Lung Cancer
- Leukoencephalopathy in Small Cell Lung Cancer Patients Receiving Prophylactic Cranial Irradiation
- Randomized trial of thoracic irradiation plus combination chemotherapy for unresectable adenocarcinoma and large cell carcinoma of the lung
- Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.